U.S. Auto Stock News

Mueller Water Products Q1 2026 Earnings Snapshot Mueller Water Products (MWA) opened fiscal 2026 with Q1 revenue of US$318.2 million and basic EPS of US$0.28, setting the tone against a trailing twelve month backdrop of US$1.44 billion in revenue and EPS of US$1.28. The company has seen quarterly revenue move from US$304.3 million and EPS of US$0.23 in Q1 2025 to US$318.2 million and EPS of US$0.28 in Q1 2026, while trailing net profit margin has lifted from 10.0% to 13.8%. This points to...

Voya Financial (VOYA) has wrapped up FY 2025 with fourth quarter revenue of US$2.1b and basic EPS of US$1.43, while net income excluding extra items came in at US$136m. The company has seen quarterly revenue move from US$2.0b and EPS of US$0.97 in Q4 2024 to US$2.1b and EPS of US$1.43 in Q4 2025. The trailing twelve months show revenue of US$8.2b, net income of US$613m and basic EPS of US$6.40, setting the backdrop for how investors judge the resilience of margins in this latest print. See...

Huron Consulting Group (HURN) opened 2026 with Q1 revenue of US$451.8 million and basic EPS of US$1.37, set against trailing twelve month revenue of about US$1.7 billion and EPS of US$6.02 as investors weigh how the latest quarter fits into the broader earnings trend. The company has seen quarterly revenue move from US$395.7 million in Q1 2025 to US$451.8 million in Q1 2026, while quarterly EPS tracked from US$1.38 to US$1.37 over the same period, leaving the headline numbers solid and...

USA Compression Partners (USAC) has wrapped up FY 2025 with fourth quarter revenue of US$252.5 million and basic EPS of US$0.22, as investors gauge how these figures fit into the wider earnings story. Over the past six quarters, revenue has moved from US$240.0 million in Q3 2024 to just under US$252.5 million in Q4 2025, while quarterly basic EPS has ranged between US$0.13 and US$0.27, sitting at US$0.22 in the latest period. With trailing twelve month net margin now at 10.3%, the release...

Insulet (NasdaqGS:PODD) has begun its pivotal EVOLVE study of a fully closed loop automated insulin delivery system for people with type 2 diabetes. The first participant has been enrolled, marking an important step in testing this technology beyond the company’s existing Omnipod 5 offering. The study focuses on expanding automated insulin delivery to a large and currently underserved segment of the diabetes population. For investors watching Insulet at a share price of $151.28, the EVOLVE...

Q1 2026 results reset the earnings story Compass (COMP) opened 2026 with Q1 revenue of US$2.7 billion and basic EPS of US$0.03, alongside trailing twelve month EPS of US$0.02 on US$8.3 billion of revenue. The company has seen quarterly revenue move from US$1.36 billion in Q1 2025 through US$1.70 billion in Q4 2025 to US$2.7 billion in Q1 2026. Basic EPS has ranged from a loss of US$0.09 in Q1 2025 to a loss of US$0.07 in Q4 2025 and then to a profit of US$0.03 in the latest quarter, setting...

Starboard Value’s new activist position in Dynatrace (DT) has turned the spotlight on the stock, with the investor urging margin expansion, faster share buybacks, and openness to options that could support shareholder value. See our latest analysis for Dynatrace. The stock has recently seen an 8% move on the Starboard announcement and a 2.69% gain on the latest trading day, yet the year to date share price return of 8.81% and 1 year total shareholder return of 18.44% both sit in negative...

If you are wondering whether Willis Lease Finance at around US$229 per share still offers value, you are not alone in asking what the current price really reflects. The stock has recently posted returns of 19.6% over 7 days, 30.2% over 30 days, 70.8% year to date and 72.3% over 1 year, with very large gains over 3 and 5 years. Recent headlines have focused on Willis Lease Finance within the capital goods and aircraft leasing space, highlighting how investors are paying closer attention to...

Q1 earnings, tax effects and new partnership shape investor focus Preformed Line Products (PLPC) drew attention after Q1 2026 results showed higher net sales but lower net income, along with a broker downgrade, a new FulcrumAir partnership, and a quarterly dividend announcement. See our latest analysis for Preformed Line Products. The stock has reacted strongly to the Q1 update, the FulcrumAir partnership and the dividend news, with a 1 month share price return of 25.33% and a year to date...

Healthpeak Properties FY 2025 earnings snapshot Healthpeak Properties (DOC) has reported new figures for FY 2025, with Q4 total revenue of US$719.4 million, basic EPS of US$0.16 and net income of US$113.8 million. These results contributed to a full year in which trailing twelve month revenue was about US$2.8 billion and EPS was US$0.10. Over recent quarters, the company’s revenue moved from US$697.9 million in Q4 FY 2024 to US$719.4 million in Q4 FY 2025, while quarterly EPS ranged from a...

Edgewise Therapeutics recently reported positive outcomes from drug trials and FDA-related developments, while also granting inducement stock options for 266,000 shares to nine new non-executive employees under its 2024 Inducement Equity Incentive Plan. These clinical updates, combined with a catalyst-rich pipeline and management’s decision to expand the team with equity-linked hires, highlight the company’s focus on executing its late- and mid-stage programs. We’ll now examine how the...

Recently, United States Antimony Corporation has faced bearish sentiment around its antimony production outlook, even as it maintains strong liquidity with solid cash and no meaningful debt but remains unprofitable. This combination of weak profitability, strong balance sheet, and uncertainty about future output has turned the company into a focal point for traders watching technical volatility and operational execution risk. We’ll now examine how concerns over United States Antimony’s...

Talen Energy (TLN) opened 2026 with Q1 revenue of US$1.1 billion and basic EPS of US$1.38, alongside trailing 12 month revenue of US$3.4 billion and a small net loss of US$21 million that translates to basic EPS of US$0.46 in the red. Over recent quarters, the company has seen revenue range from US$454 million to US$1.1 billion and basic EPS swing between a loss of US$7.95 and a gain of US$4.53. This sets up a results season where investors will be focused on how consistently those higher...

Entravision Communications (EVC) has opened 2026 with Q1 revenue of US$197.0 million and basic EPS of US$0.13, alongside net income from ongoing operations of US$12.4 million. The company has seen revenue move from US$91.9 million in Q1 2025 and US$107.0 million in Q4 2024 to US$197.0 million in Q1 2026. EPS has shifted from losses of US$0.53 and US$0.62 in those respective quarters to a profit in the latest period, setting up a quarter where investors will be focused on how durable these...

BigBear.ai Holdings (BBAI) opened Q1 2026 with revenue of about US$34.4 million and a basic EPS loss of roughly US$0.12, setting the tone for another quarter where growth and profitability are pulling in different directions. Over recent periods, revenue has moved between US$27.3 million and US$43.8 million a quarter, while basic EPS has ranged from a small profit of about US$0.01 to a loss of roughly US$0.71, underscoring how volatile margins have been as the business scales. In that...

TrueBlue FY 2025 earnings snapshot TrueBlue (TBI) has capped FY 2025 with fourth quarter revenue of US$418.2 million and a basic EPS loss of US$1.05. On a trailing twelve month view, revenue sits at about US$1.6 billion and EPS is a loss of US$1.61. Over recent quarters the company has reported revenue of US$382.4 million in Q3 2024 and US$418.2 million in Q4 2025, while quarterly EPS has ranged from a loss of US$0.26 in Q3 2024 to a loss of US$1.05 in Q4 2025. Margins remain under pressure,...

Angi (ANGI) posts FY 2025 results with steady profitability and modest top line Angi (ANGI) closed FY 2025 with fourth quarter revenue of US$240.8 million and basic EPS of US$0.17, while trailing twelve month EPS reached US$0.96 on net income of US$43.8 million, setting a clear reference point for the year at a share price of US$7.41. Over the past six reported quarters, revenue has ranged from US$240.8 million to US$296.7 million, while quarterly basic EPS has moved between a loss of US$0.03...

Genworth Financial (GNW) just closed FY 2025 with fourth quarter revenue of US$1.8 billion and a basic EPS loss of US$0.05, compared with revenue of US$1.8 billion and basic EPS of US$0.01 in the prior year’s fourth quarter. Over the past year, revenue across reported periods has sat in a tight band between US$1.8 billion and US$1.9 billion per quarter. Quarterly EPS has shifted from a small profit of US$0.01 in Q4 2024 to US$0.30 in Q3 2025 before slipping back into a modest loss in Q4 2025...

Remitly Global (RELY) is back in focus after expanding its WhatsApp Send service, adding more supported countries and a new Request Money feature just ahead of its Q1 2026 results on May 6. See our latest analysis for Remitly Global. The WhatsApp expansion and anticipation around Q1 2026 have come alongside strong momentum, with an approximately 46% 1 month share price return, an 85% 3 month share price return, and a 12.6% 1 year total shareholder return, suggesting sentiment has improved...

Ultra Clean Holdings (UCTT) is back on investors’ radar after being lifted to a top Zacks Rank, with analysts raising earnings estimates in response to AI infrastructure demand and upgrades in wafer fab equipment spending. See our latest analysis for Ultra Clean Holdings. The stock’s momentum has been strong, with a 93.44% 90 day share price return and a 204.32% year to date share price return, contributing to a 332.35% 1 year total shareholder return as AI infrastructure interest and...

Phathom Pharmaceuticals (PHAT) recently reported first quarter results showing a net loss of US$30.37 million, alongside reaffirmed 2026 guidance that includes an operating profitability target beginning in the third quarter. See our latest analysis for Phathom Pharmaceuticals. The stock’s recent 12.62% 1 month share price return, alongside a 7.56% 7 day gain, contrasts with a 19.35% year to date share price decline. At the same time, the 1 year total shareholder return above 400% highlights...

Alto Ingredients, Inc. has already reported its Q1 2026 results, posting net income of US$4.0 million and Adjusted EBITDA of US$4.7 million, reflecting a return to profitability versus losses a year earlier. Management linked the turnaround to strong export sales, improved crush margins, new Section 45Z tax credit benefits, and an US$8.1 million unrealized derivative gain, while outlining plans to further monetize biogenic CO2 to lower the company’s carbon footprint. Next, we’ll examine how...

Hecla Mining (HL) earnings snapshot Hecla Mining (HL) has put fresh numbers on the table for Q1 2026, with revenue of US$411.4 million, basic EPS of US$0.25 and net income from continuing operations of US$164.5 million, while also reporting earnings from discontinued operations of US$183.7 million. Over the past year, the company has seen revenue move from US$929.9 million on a trailing basis to US$1.57 billion and EPS shift from US$0.06 to US$0.69, alongside a very large year over year...

Select Water Solutions (WTTR) just wrapped up FY 2025 with Q4 revenue of US$346.5 million and a small net loss of US$0.3 million, equal to EPS of roughly US$0.00, while shares recently traded around US$17.25. Over the past few quarters, the company has seen revenue move between US$322.2 million and US$374.4 million, with EPS ranging from a loss of about US$0.02 in late 2024 to a high of roughly US$0.10 in Q2 2025. For investors, the mix of modest trailing net profit margin of 1.5% and...